Skip to main content
Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
40.66
+1.52 (3.88%)
At close: Dec 20, 2024, 4:00 PM
40.90
+0.24 (0.59%)
After-hours: Dec 20, 2024, 7:54 PM EST

Kymera Therapeutics Revenue

Kymera Therapeutics had revenue of $3.74M in the quarter ending September 30, 2024, a decrease of -20.88%. This brings the company's revenue in the last twelve months to $87.56M, up 86.92% year-over-year. In the year 2023, Kymera Therapeutics had annual revenue of $78.59M with 67.84% growth.

Revenue (ttm)
$87.56M
Revenue Growth
+86.92%
P/S Ratio
32.33
Revenue / Employee
$468,251
Employees
187
Market Cap
2.63B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202378.59M31.77M67.84%
Dec 31, 202246.83M-26.01M-35.71%
Dec 31, 202172.83M38.80M114.00%
Dec 31, 202034.03M31.10M1,059.99%
Dec 31, 20192.93M--
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Patterson Companies 6.55B
Surgery Partners 2.99B
Concentra Group Holdings Parent 1.88B
LivaNova 1.24B
Neogen 912.20M
HUTCHMED (China) 610.81M
Catalyst Pharmaceuticals 460.48M
SpringWorks Therapeutics 135.49M
Revenue Rankings

KYMR News

More News